Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Shu

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Clinical and Translational Medicine|November 2, 2020
A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancerWei-Da Wang, Guo-Yan Wu, Kun-Hao Bai, et al.
Leukemia|March 9, 2021
A prognostic survival model based on metabolism-related gene expression in plasma cell myelomaHan-Ying Huang, Yun Wang, Wei-da Wang, et al.
International Immunopharmacology|October 4, 2021
The monomer derivative of paeoniflorin inhibits macrophage pyroptosis via regulating TLR4/ NLRP3/ GSDMD signaling pathway in adjuvant arthritis ratsLi Xu, Han Wang, Qian-Qian Yu, et al.
Frontiers in Pharmacology|June 2, 2020
Etanercept Inhibits B Cell Differentiation by Regulating TNFRII/TRAF2/NF-<i>κ</i>B Signaling Pathway in Rheumatoid ArthritisXiao-Yu Cai, Yue Zhu, Chen Wang, et al.
Phytotherapy Research : PTR|October 2, 2020
Paeoniflorin-6'-o-benzene sulfonate (CP-25) improves vasculitis through inhibiting IL-17A/JAK/STAT3 signaling pathway in endothelial cells of HFD CIA ratsXiao-Yu Cai, Jing-Ru Ge, Li Xu, et al.
Acta Pharmacologica Sinica|November 18, 2018
Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agentsJin-Ling Shu, Xian-Zheng Zhang, Le Han, et al.
Frontiers in Pharmacology|January 10, 2018
CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological AgentsFeng Zhang, Jin-Ling Shu, Ying Li, et al.
Gastroenterology Report|January 23, 2023
Artificial intelligence empowers the second-observer strategy for colonoscopy: a randomized clinical trialPu Wang, Xiao-Gang Liu, Min Kang, et al.
Acta Pharmacologica Sinica|January 16, 2020
IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-κB signaling pathwaysLe Han, Xian-Zheng Zhang, Chen Wang, et al.
ACS Nano|August 20, 2025
Ultraselective Amino-Phenolic Nanofiltration Membranes via Enzyme-Mediated Decoupling of Diffusion and ReactionPing Fu, Jia-Hui Xin, Wan-Long Li, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Clinical and Translational Medicine|November 2, 2020
A prognostic stemness biomarker CCDC80 reveals acquired drug resistance and immune infiltration in colorectal cancerWei-Da Wang, Guo-Yan Wu, Kun-Hao Bai, et al.
Leukemia|March 9, 2021
A prognostic survival model based on metabolism-related gene expression in plasma cell myelomaHan-Ying Huang, Yun Wang, Wei-da Wang, et al.
International Immunopharmacology|October 4, 2021
The monomer derivative of paeoniflorin inhibits macrophage pyroptosis via regulating TLR4/ NLRP3/ GSDMD signaling pathway in adjuvant arthritis ratsLi Xu, Han Wang, Qian-Qian Yu, et al.
Frontiers in Pharmacology|June 2, 2020
Etanercept Inhibits B Cell Differentiation by Regulating TNFRII/TRAF2/NF-<i>κ</i>B Signaling Pathway in Rheumatoid ArthritisXiao-Yu Cai, Yue Zhu, Chen Wang, et al.
Phytotherapy Research : PTR|October 2, 2020
Paeoniflorin-6'-o-benzene sulfonate (CP-25) improves vasculitis through inhibiting IL-17A/JAK/STAT3 signaling pathway in endothelial cells of HFD CIA ratsXiao-Yu Cai, Jing-Ru Ge, Li Xu, et al.
Acta Pharmacologica Sinica|November 18, 2018
Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agentsJin-Ling Shu, Xian-Zheng Zhang, Le Han, et al.
Frontiers in Pharmacology|January 10, 2018
CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological AgentsFeng Zhang, Jin-Ling Shu, Ying Li, et al.
Gastroenterology Report|January 23, 2023
Artificial intelligence empowers the second-observer strategy for colonoscopy: a randomized clinical trialPu Wang, Xiao-Gang Liu, Min Kang, et al.
Acta Pharmacologica Sinica|January 16, 2020
IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-κB signaling pathwaysLe Han, Xian-Zheng Zhang, Chen Wang, et al.
ACS Nano|August 20, 2025
Ultraselective Amino-Phenolic Nanofiltration Membranes via Enzyme-Mediated Decoupling of Diffusion and ReactionPing Fu, Jia-Hui Xin, Wan-Long Li, et al.
Pageof 14